Bringing Stem Cell‐Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost‐Effectiveness Analysis-Reference-Cited by-同舟云学术

Bringing Stem Cell‐Based Therapies for Type 1 Diabetes to the Clinic: Early Insights from Bioprocess Economics and Cost‐Effectiveness Analysis

Published:2019-07-08 Issue:8 Volume:14 Page:1800563
ISSN:1860-6768
Container-title:Biotechnology Journal
language:en
Short-container-title:Biotechnol. J.

Author:

Bandeiras Cátia¹²³,Cabral Joaquim M. S.¹²,Gabbay Robert A.⁴,Finkelstein Stan N.³⁵,Ferreira Frederico Castelo¹²^ORCID

Affiliation:

1. Department of Bioengineering, iBB—Institute for Bioengineering and Biosciences, Instituto Superior TécnicoUniversidade de Lisboa 1049‐001 Lisboa Portugal

2. The Discoveries Center for Regenerative and Precision Medicine, Lisbon CampusInstituto Superior Técnico, Universidade de Lisboa 1049‐001 Lisboa Portugal

3. Division of Clinical Informatics, Department of MedicineBeth Israel Deaconess Medical Center 1330 Beacon Street Brookline MA 02446 USA

4. Joslin Diabetes Medical CenterHarvard Medical School One Joslin Place Boston MA 02216 USA

5. Institute for Data, Systems and SocietyMassachusetts Institute of Technology 50 Ames Street Cambridge MA 02139 USA

Funder

Fundação para a Ciência e a Tecnologia

Publisher

Wiley

Subject

Molecular Medicine,Applied Microbiology and Biotechnology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biot.201800563

Reference49 articles.

1. On type 1 diabetes mellitus pathogenesis

2. M. Beckstrand Walden Dissertations and Doctoral Studies Walden University 2015.

3. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

4. Estimating the Cost of Type 1 Diabetes in the U.S.: A Propensity Score Matching Method

5. A health economic analysis of clinical islet transplantation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges;Endocrine;2024-05-10

2. An unmet need: Pancreatic beta cell replacement;SAMJ S AFR MED J;2024

3. The future treatment for type 1 diabetes: Pig islet- or stem cell-derived β cells?;Frontiers in Endocrinology;2023-01-05

4. BEMSCA: A novel decision support tool applied to the optimal design of a large-scale human induced pluripotent stem cell expansion bioprocess;Current Research in Biotechnology;2023

5. Bioprocess Economic Modeling: Decision Support Tools for the Development of Stem Cell Therapy Products;Bioengineering;2022-12-11